Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > PHVS Pharvaris > Detailed Quotes

PHVS Pharvaris

7.670
-0.310-3.88%
Close 09/29 16:00 ET
High
7.990
Open
7.990
Turnover
13.14K
Low
7.001
Pre Close
7.980
Volume
1.79K
Market Cap
258.98M
P/E(TTM)
Loss
52wk High
27.500
Shares
33.77M
P/E(Static)
Loss
52wk Low
7.001
Float Cap
63.55M
Bid/Ask %
33.33%
Historical High
42.860
Shs Float
8.29M
Volume Ratio
0.32
Historical Low
7.001
Dividend TTM
--
Div Yield TTM
--
P/B
1.36
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.02%
Amplitude
12.39%
Avg Price
7.349
Lot Size
1
Float Cap
63.55M
Bid/Ask %
33.33%
Historical High
42.860
Shs Float
8.29M
Volume Ratio
0.32
Historical Low
7.001
Dividend TTM
--
P/B
1.36
Dividend LFY
--
Turnover Ratio
0.02%
Amplitude
12.39%
Avg Price
7.349
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Pharvaris NV operates as a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of innovative therapies for rare diseases focused on angioedema and other bradykinin-mediated diseases. Its PHA121 program is designed to treat all sub-types of hereditary angioedema. The company was founded by Luc Dochez, Jens Schneider-Mergener, Berndt A. E. Modig, Jochen Knolle, Hans Gerardus Christiaan Petrus Schikan, and Anne Lesage on September 30, 2015 and is headquartered in Leiden, the Netherlands.
CEO: Mr. Berndt Modig
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...